Prophylactic Pulmonary Vein Isolation Study

Sponsor
Mayo Clinic (Other)
Overall Status
Terminated
CT.gov ID
NCT00587899
Collaborator
(none)
41
1
2
34
1.2

Study Details

Study Description

Brief Summary

This study is being done to learn the effects of the Pulmonary Vein Isolation in patients that are at high risk to developing, but do not have a documented history of atrial fibrillation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pulmonary Vein Isolation
N/A

Detailed Description

Patients with a dilated left atrium (left upper chamber of the heart) that undergo mitral valve surgery may be at risk for the development of atrial fibrillation after surgery.

Atrial fibrillation (also known as "A-Fib" or AF) is an abnormal heart rhythm which may cause symptoms such as pounding sensations in your chest, dizziness, fatigue, chest pain and/or shortness of breath. AF patients are at a higher risk of developing a stroke.

Participants who sign informed consent will be randomized into one of two groups by chance (as in the flip of a coin).

Approximately 77 patients will undergo their mitral valve operation along with Pulmonary Vein Isolation (a treatment group) and 77 patients who do not undergo Pulmonary Vein Isolation at the time of their mitral valve surgery (a control group).

The treatment group will undergo operation for mitral valve disease with an additional procedure called Pulmonary Vein Isolation using a device that delivers radiofrequency energy to the heart muscle in order to create scar tissue to block electrical impulses that can trigger episodes of AF.

The control group of patients will undergo operation for mitral valve disease without the additional Pulmonary Vein Isolation.

Study Design

Study Type:
Interventional
Actual Enrollment :
41 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
A Randomized, Single-blind Prophylactic Pulmonary Vein Isolation Procedure Utilizing Bipolar Radiofrequency Ablation in Patients Undergoing Mitral Valve Surgery
Study Start Date :
Jan 1, 2007
Actual Primary Completion Date :
Nov 1, 2009
Actual Study Completion Date :
Nov 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Other: 1

The treatment group will undergo operation for mitral valve disease with an additional procedure called Pulmonary Vein Isolation.

Procedure: Pulmonary Vein Isolation
The treatment group will undergo operation for mitral valve disease with an additional procedure called Pulmonary Vein Isolation using a device that delivers radiofrequency energy to the heart muscle in order to create scar tissue to block electrical impulses that can trigger episodes of AF.

No Intervention: 2

The control group of patients will undergo operation for mitral valve disease without the additional Pulmonary Vein Isolation

Outcome Measures

Primary Outcome Measures

  1. Evaluated by the number of patients free of taking antiarrhythmic medications and free of AF as determined by a 24-hour Holter recording. [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Indication for open-heart surgery: Mitral valve repair or replacement, evidence of a dilated left atrium
Exclusion Criteria:
  • History of Atrial Fibrillation

  • Need for emergent cardiac surgery

  • Previous cardiac surgery

  • Preoperative need for an intraaortic balloon pump or intravenous inotropes

  • Current diagnosis of active endocarditis

  • Mental impairment/or experience other conditions which may not allow subject to understand nature

  • Significance and scope of study

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Rochester Minnesota United States 55902

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Thoralf M. Sundt, III, M.D., Professor of Surgery, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00587899
Other Study ID Numbers:
  • 06-005543
First Posted:
Jan 8, 2008
Last Update Posted:
Apr 14, 2011
Last Verified:
Apr 1, 2011
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 14, 2011